Unknown PHASE4 INTERVENTIONAL NCT00241930

Integrating Buprenorphine Into HIV Treatment

SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model

Sponsor: Organization to Achieve Solutions in Substance Abuse (OASIS)

Conditions HIV Infections Opiate Dependence

Interventions Integrating drug treatment into HIV services

Updated 5 times since 2017 Last updated: Oct 24, 2005 Started: Sep 30, 2005 Completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on HIV Infections and Opiate Dependence, this trial is ongoing. The trial is conducted by Organization to Achieve Solutions in Substance Abuse (OASIS) and has accumulated 5 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Organization to Achieve Solutions in Substance Abuse (OASIS)

Data source: Organization to Achieve Solutions in Substance Abuse (OASIS)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oakland, United States
• San Leandro, United States